Select company
- Ticker/CompanyMarket Cap.
No results found
Select metric
Pick a metric...
2.04Price to Book
VS
Market
Sector
Industry
History
$ 11.12Close
$ 4.26 - $ 15.16 52-Week Range
Ticker Information
Ticker
ENTACompany Name
ENANTA PHARMACEUTICALS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQENANTA PHARMACEUTICALS INC - Price to Book Chart Analysis (TTM)
From
Zoom
1Y
3Y
5Y
10Y
ENTA - P/B Historical data
| Date | Shareholders Equity | Market Capitalization | Price to Book |
|---|---|---|---|
| 6/30/2025 | $ 79.28M | $ 162.04M | 2.04 |
| 3/31/2025 | $ 93.54M | $ 110.73M | 1.18 |
| 12/31/2024 | $ 111.82M | $ 125.01M | 1.12 |
| 9/30/2024 | $ 128.81M | $ 187.15M | 1.45 |
| 6/30/2024 | $ 148.91M | $ 262.1M | 1.76 |
| 3/31/2024 | $ 166.11M | $ 270.25M | 1.63 |
| 12/31/2023 | $ 191.88M | $ 261.49M | 1.36 |
| 9/30/2023 | $ 216.74M | $ 189.32M | 0.87 |
| 6/30/2023 | $ 237.82M | $ 389.95M | 1.64 |
| 3/31/2023 | $ 269.38M | $ 537.33M | 1.99 |
Key Performance Insights, Last 5 Years
- ENANTA PHARMACEUTICALS INC's latest trailing twelve months (TTM) P/B stands at 1.89.
- Over the past 5 years, ENANTA PHARMACEUTICALS INC's average P/B has been 2.28.
- The median P/B for ENANTA PHARMACEUTICALS INC during this period was 2.02
- ENANTA PHARMACEUTICALS INC reached its highest P/B over the past 5 years at 4.42.
- The lowest P/B recorded by ENANTA PHARMACEUTICALS INC in the same timeframe 0.87
ENANTA PHARMACEUTICALS INC's P/B vs. competitors
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
P/B Benchmarks
Similar metrics to P/B:
- Price to Sales - [Calculation] Measures a company’s [MarketCap] in relation to its [Revenue].
- Free Cash Flow Yield - [Calculation] The Free Cash Flow Yield, also known as the inverse of the Price to Free Cash Flow ratio [PFCF], expresses a company’s Free Cash Flow [FCF] as a percentage of [MarketCap.
- Price to Free Cash Flow - [Calculation] Measures a company’s [MarketCap] in relation to its Free Cash Flow [FCF].
- Price to Operating Cash Flow - [Calculation] Measures a company’s [MarketCap] in relation to its Operating Cash Flow [NCFO].
- Shareholders Equity - [Balance Sheet] A principal component of the balance sheet; in addition to [Liabilities] and [Assets]; that represents the total of all stockholders' equity (deficit) after all liabilities have been deducted.
Definition of Price to Book
[Calculation] Measures a company’s [MarketCap] in relation to its [Equity] which is the value of [Assets] minus [Liabilities].Market Cap / Equity
(=) P/B P/B for ENANTA PHARMACEUTICALS INC is calculated as follows: Market Cap [ $ 862.19M ] / Equity [ $ 455.58M ]
(=) P/B [ 1.89 ] ENTA - Price to Book, Last 5 years
0.87
Minimum
Sep 30, 2023
4.42
Maximum
Sep 30, 2021
2.28
Average
2.02
Median
P/B Benchmark AnalysisMarket
The chart above depicts the distribution of P/B for companies in the Total Stock Market. The average P/B of the companies is 2.29 with a standard deviation of 1.81.
The following table provides additional summary stats:
P/B in the Market:
| filtered constituents | 3.36K |
|---|---|
| min | 0 |
| max | 8.04 |
| average | 2.29 |
| median | 1.63 |
| std | 1.81 |